SAN CARLOS, Calif. (AP) _ Iovance Biotherapeutics Inc. (IOVA) on Monday reported a loss of $30.7 million in its second quarter.
The San Carlos, California-based company said it had a loss of 34 cents per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.
Iovance Biotherapeutics shares have increased 83 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $14.65, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA